• Dry Cracked Skin
  • Impetigo
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

Drug Watch: What's Coming in Acne Treatment?


In this drug pipeline interview, Christopher Bunick, MD, PhD, discusses what is innovative in future acne treatment options, what research is happening, and what potential approvals the dermatology space has to look forward to.

Christopher Bunick, MD, PhD, Dermatology Times® editorial board member and physician-scientist practicing general medical and surgical dermatology at Yale University, in New Haven, Connecticut, dives into the acne drug pipeline. Hear his notes on what potenital new treatments are coming for acne vulgaris, exciting research advancements in the space, and much more.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.